PSMA3 and cholangiocarcinoma: Finding increased levels of plasma S100A9, AACT, NGAL, and PSMA3 proteins in 26 CCA patients relative to 20 normal individuals and 17 patients with non-CCA diseases allowed us to develop the All-7 and the Sig-4 panels.